News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aerpio Appoints Dr. Adrienne Graves to Board of Directors


5/10/2012 10:35:23 AM

CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics, a clinical-stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory bowel disease, today announced the appointment of Adrienne Graves, Ph.D., to its Board of Directors.

Read at BioSpace.com

comments powered by Disqus
Aerpio
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES